Vr Adviser, LLC Vista Gen Therapeutics, Inc. Transaction History

Vr Adviser, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 May 15, 2023	BUY	$0.88 - $1.73 $18.2 Million - $35.8 Million	20,697,286 New	20,697,286 $18.2 Million
Q2 2022 Aug 15, 2022	BUY	$0.88 - $1.73 $4.09 Million - $8.04 Million	4,650,000 Added 28.98%	20,697,286 $18.2 Million
Q2 2021 Aug 13, 2021	SELL	$1.96 - $3.15 $500,407 - $804,226	-255,310 Reduced 1.57%	16,047,286 $50.5 Million
Q1 2021 May 14, 2021	BUY	$1.89 - $2.96 $13.1 Million - $20.6 Million	6,942,596 Added 74.17%	16,302,596 $34.7 Million
Q4 2020 Feb 12, 2021	BUY	$0.65 - $1.94 $6.08 Million - $18.2 Million	9,360,000 New	9,360,000 $18.2 Million

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $623M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Vr Adviser, LLC, based on Form 13F filings with the SEC.

Stay updated on Vr Adviser, LLC with notifications on news.